Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mark D. Ewalt & Dita Gratzinger. (2016) Selective quantitation of microvessel density reveals sinusoidal expansion in myelodysplastic syndromes. Leukemia & Lymphoma 57:12, pages 2923-2926.
Read now
Read now
Asmaa Ahmed AbdElAal, Reham Abdel Aleem Afify, Amr ElSayed Zaher, Mosaad Mahmoud ElGammal & Asmaa M. Atef. (2015) Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia. Hematology 20:9, pages 504-510.
Read now
Read now
Houda Haouas. (2014) Angiogenesis and acute myeloid leukemia. Hematology 19:6, pages 311-323.
Read now
Read now
Gülsan Türköz Sucak, Şahika Zeynep Aki, Bilgehan YüzbaşioĞlu, Nalân Akyürek, Münci YaĞci, Ümit BaĞriaçik & Rauf Haznedar. (2011) Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant. Leukemia & Lymphoma 52:7, pages 1281-1289.
Read now
Read now
Articles from other publishers (45)
Kesiya Thomas, Ranjitha Rao, Chaithra G V, Sharada Rai, Sneha Rao A R & Kudurugundi Basavaraju Vatsala. (2023) Study of significance of bone marrow microvessel density in myeloproliferative neoplasms in correlation with CD34 blasts, mast cell count and fibrosis. F1000Research 12, pages 503.
Crossref
Crossref
Kesiya Thomas, Ranjitha Rao, Chaithra G V, Sharada Rai, Sneha Rao A R & Kudurugundi Basavaraju Vatsala. (2023) Study of significance of bone marrow microvessel density in myeloproliferative neoplasms in correlation with CD34 blasts, mast cell count and fibrosis. F1000Research 12, pages 503.
Crossref
Crossref
Xin Zhao, Huan-qiu Liu, Li-na Wang, Le Yang & Xiao-liang Liu. (2022) Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities. Seminars in Cancer Biology 83, pages 121-135.
Crossref
Crossref
Joan How, Siyang Ren, Jennifer Lombardi‐Story, Meghan Bergeron, Julia Foster, Phillip C. Amrein, Andrew M. Brunner, Amir T. Fathi, Hanno Hock, Anna Khachatryan, Hiroto Kikuchi, Mei Rosa Ng, Jenna Moran, Rupa Narayan, Donna Neuberg, Aura Ramos, Tina Som, Meghan Vartanian, Yi‐Bin Chen, Dan G. Duda & Gabriela S. Hobbs. (2022) A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies. eJHaem 3:2, pages 434-442.
Crossref
Crossref
Débora Bifano Pimenta, Vanessa Araujo Varela, Tarcila Santos Datoguia, Victória Bulcão Caraciolo, Gabriel Herculano Lopes & Welbert Oliveira Pereira. (2021) The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Jinman Zhong, Hang Wu, Xiaoyin Bu, Weiru Li, Shengchun Cai, Meixue Du, Ya Gao & Baohong Ping. (2021) Establishment of Prognosis Model in Acute Myeloid Leukemia Based on Hypoxia Microenvironment, and Exploration of Hypoxia-Related Mechanisms. Frontiers in Genetics 12.
Crossref
Crossref
Laura Mosteo, Joanna Storer, Kiran Batta, Emma J. Searle, Delfim Duarte & Daniel H. Wiseman. (2021) The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid Malignancy. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Unnikrishnan Sivan, Jessica De Angelis, Saravana K. Ramasamy & Anjali P. Kusumbe. 2021. The Cancer Stem Cell Niche. The Cancer Stem Cell Niche
63
84
.
Manman Deng, Jie Zha, Haijun Zhao, Xian Jia, Yuanfei Shi, Zhifeng Li, Guo Fu, Lian Yu, Zhihong Fang & Bing Xu. (2020) Apatinib exhibits cytotoxicity toward leukemia cells by targeting VEGFR2-mediated prosurvival signaling and angiogenesis. Experimental Cell Research 390:1, pages 111934.
Crossref
Crossref
Jianting Li, Wenjin Li, Jinliang Niu, Xiaoli Song, Wenqi Wu, Tong Gong, Rong Zheng, Tiffany Ting-Fang Shih, Weiguo Li & Xiaohong Joe Zhou. (2020) Intravoxel Incoherent Motion Diffusion-weighted MRI of Infiltrated Marrow for Predicting Overall Survival in Newly Diagnosed Acute Myeloid Leukemia. Radiology 295:1, pages 155-161.
Crossref
Crossref
Rong Fan, Hong Zhu, Jinliang Niu, Jianting Li, Rong Zheng & Xiaoli Song. (2020) Correlation of histological marrow characteristics and intravoxel incoherent motion-derived parameters in benign and malignant hematological disorders. European Journal of Radiology 123, pages 108745.
Crossref
Crossref
Fatih M. Uckun, Christopher R. Cogle, Tara L. Lin, Sanjive Qazi, Vuong N. Trieu, Gary Schiller & Justin M. Watts. (2019) A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia. Cancers 12:1, pages 74.
Crossref
Crossref
Binyan Lin, Kai Zhao, Dawei Yang, Dongsheng Bai, Yan Liao, Yuxin Zhou, Zhou Yu, Xiaoxuan Yu, Qinglong Guo & Na Lu. (2018) Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis. Journal of Cellular Physiology 234:2, pages 1913-1924.
Crossref
Crossref
Lena Behrmann, Jasmin Wellbrock & Walter Fiedler. (2018) Acute Myeloid Leukemia and the Bone Marrow Niche—Take a Closer Look. Frontiers in Oncology 8.
Crossref
Crossref
Hui Cheng, Guohuan Sun & Tao Cheng. (2018) Hematopoiesis and microenvironment in hematological malignancies. Cell Regeneration 7:1, pages 22-26.
Crossref
Crossref
Tiffany Ting-Fang Shih. (2016) Angiogenesis in hematological malignancy – Evaluated by dynamic contrast-enhanced MRI. Journal of Cancer Research and Practice 3:4, pages 97-103.
Crossref
Crossref
Ronan T. Swords, Peter L. Greenberg, Andrew H. Wei, Simon Durrant, Anjali S. Advani, Mark S. Hertzberg, Ian D. Lewis, Gabriel Rivera, Dita Gratzinger, Alice C. Fan, Dean W. Felsher, Jorge E. Cortes, Justin M. Watts, Geoff T. Yarranton, Jackie M. Walling & Jeffrey E. Lancet. (2016) KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study. Leukemia Research 50, pages 123-131.
Crossref
Crossref
Christopher R. Cogle, Raphael C. Bosse, Takae Brewer, Yazan Migdady, Reza Shirzad, Kim Rosalie Kampen & Najmaldin Saki. (2016) Acute myeloid leukemia in the vascular niche. Cancer Letters 380:2, pages 552-560.
Crossref
Crossref
R. Shirzad, S. Shahrabi, A. Ahmadzadeh, K. R. Kampen, M. Shahjahani & N. Saki. (2016) Signaling and molecular basis of bone marrow niche angiogenesis in leukemia. Clinical and Translational Oncology 18:10, pages 957-971.
Crossref
Crossref
Raphael C. Bosse, Briana Wasserstrom, Amy Meacham, Elizabeth Wise, Leylah Drusbosky, Glenn A. Walter, David J. Chaplin, Dietmar W. Siemann, Daniel L. Purich & Christopher R. Cogle. (2016) Chemosensitizing AML cells by targeting bone marrow endothelial cells. Experimental Hematology 44:5, pages 363-377.e5.
Crossref
Crossref
Antonia Reale, Assunta Melaccio, Aurelia Lamanuzzi, Ilaria Saltarella, Franco Dammacco, Angelo Vacca & Roberto Ria. (2016) Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies. Stem Cells International 2016, pages 1-11.
Crossref
Crossref
YANQIU SONG, YAN TAN, LIBO LIU, QIAN WANG, JING ZHU & MIN LIU. (2015) Levels of bone marrow microvessel density are crucial for evaluating the status of acute myeloid leukemia. Oncology Letters 10:1, pages 211-215.
Crossref
Crossref
Michael G. Poulos, Eric J. Gars, Michael C. Gutkin, Christopher C. Kloss, Michael Ginsberg, Joseph M. Scandura, Shahin Rafii & Jason M. Butler. (2014) Activation of the vascular niche supports leukemic progression and resistance to chemotherapy. Experimental Hematology 42:11, pages 976-986.e3.
Crossref
Crossref
Pannee Praditsuktavorn & Jia Ruan. 2014. Metronomic Chemotherapy. Metronomic Chemotherapy
173
188
.
Domenico Ribatti. (2013) Angiogenesis as a treatment target in leukemia. International Journal of Hematologic Oncology 2:3, pages 229-242.
Crossref
Crossref
Kimberley J. Hatfield, Lasse Evensen, Håkon Reikvam, James B. Lorens & Øystein Bruserud. (2012) Soluble mediators released by acute myeloid leukemia cells increase capillary‐like networks. European Journal of Haematology 89:6, pages 478-490.
Crossref
Crossref
V. Carrai, I. Miniati, S. Guiducci, G. Capaccioli, R. Alterini, R. Saccardi, M. L. Conforti, L. Rigacci, G. Rotunno, A. Bosi & M. M. Cerinic. (2012) Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. Rheumatology 51:6, pages 1042-1048.
Crossref
Crossref
Angelica Trujillo, Christie McGee & Christopher R. Cogle. (2012) Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies. Journal of Oncology 2012, pages 1-9.
Crossref
Crossref
Baijun Fang, Yuzhang Liu, Jian Zhou, Yanan Li & Yongping Song. (2011) Salvage therapy with endostatin, low‐dose homoharringtonine, and cytarabine in combination with granulocyte‐colony stimulating factor for elderly patients with primary refractory acute myeloid leukemia. American Journal of Hematology 87:1, pages 126-127.
Crossref
Crossref
Wei Gao, Guoqiang Chang, Jian Wang, Weina Jin, Lihong Wang, Yani Lin, Huawen Li, Li Ma, Qinghua Li & Tianxiang Pang. (2011) Inhibition of K562 leukemia angiogenesis and growth by selective Na+/H+ exchanger inhibitor cariporide through down-regulation of pro-angiogenesis factor VEGF. Leukemia Research 35:11, pages 1506-1511.
Crossref
Crossref
Abdullah Hacıhanefioglu, Emel Gonullu, Ozgur Mehtap, Hakan Keski, Melike Yavuz & Cengiz Ercin. (2010) Effect of heat shock protein-90 (HSP90) and vascular endothelial growth factor (VEGF) on survival in acute lymphoblastic leukemia: an immunohistochemical study. Medical Oncology 28:3, pages 846-851.
Crossref
Crossref
Gerard J. Madlambayan, Amy M. Meacham, Koji Hosaka, Saad MirMarda Jorgensen, Edward W. Scott, Dietmar W. Siemann & Christopher R. Cogle. (2010) Leukemia regression by vascular disruption and antiangiogenic therapy. Blood 116:9, pages 1539-1547.
Crossref
Crossref
Nuria Barbarroja, Luis-Arístides Torres, Antonio Rodriguez-Ariza, Araceli Valverde-Estepa, Laura Maria Lopez-Sanchez, Patricia Ruiz-Limon, Carlos Perez-Sanchez, Rosario Maria Carretero, Francisco Velasco & Chary López-Pedrera. (2010) AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia. Experimental Hematology 38:8, pages 641-652.
Crossref
Crossref
Walter Fiedler, Rolf Mesters, Michael Heuser, Gerhard Ehninger, Wolfgang E. Berdel, Ute Zirrgiebel, Jane D. Robertson, Tom A. Puchalski, Barbara Collins, Juliane M. Jürgensmeier & Hubert Serve. (2010) An open-label, Phase I study of cediranib (RECENTIN™) in patients with acute myeloid leukemia. Leukemia Research 34:2, pages 196-202.
Crossref
Crossref
P. J. Simpson-Haidaris, S. J. Pollock, S. Ramon, N. Guo, C. F. Woeller, S. E. Feldon & R. P. Phipps. (2010)
Anticancer Role of PPAR
Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
. PPAR Research 2010, pages 1-36.
Crossref
Crossref
Eva Diffner, Fredrika Gauffin, Lola Anagnostaki, Ann Nordgren, Bertil Gustafsson, Birgitta Sander, Britt Gustafsson & Jenny Liao Persson. (2009) Expression of VEGF and VEGF Receptors in Childhood Precursor B-cell Acute Lymphoblastic Leukemia Evaluated by Immunohistochemistry. Journal of Pediatric Hematology/Oncology 31:9, pages 696-701.
Crossref
Crossref
Tiffany Ting-Fang Shih, Hsin-An HouChieh-Yu LiuBang-Bin Chen, Jih-Luh TangHsuan-Yu Chen, Shwu-Yuan Wei, Ming YaoShang-Yi HuangWen-Chien Chou, Szu-Chun Hsu, Woei TsayChih-Wei Yu, Chao-Yu Hsu, Hwei-Fang TienPan-Chyr Yang. (2009) Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival. Blood 113:14, pages 3161-3167.
Crossref
Crossref
Judah Folkman & Joseph E. ItalianoJr.Jr.. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood
27
40
.
Margaret E. Macy, Kelly K. Sawczyn, Timothy P. Garrington, Douglas K. Graham & Lia Gore. (2008) Pediatric developmental therapies: Interesting new drugs now in early-stage clinical trials. Current Oncology Reports 10:6, pages 477-490.
Crossref
Crossref
Isabelle PetitMatthias A. KarajannisLoic VincentLauren YoungJason ButlerAndrea T. HooperKoji ShidoHermann Steller, David J. Chaplin, Eric FeldmanShahin Rafii. (2008) The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death. Blood 111:4, pages 1951-1961.
Crossref
Crossref
Xunwei Dong, Zhong Chao Han & Renchi Yang. (2007) Angiogenesis and antiangiogenic therapy in hematologic malignancies. Critical Reviews in Oncology/Hematology 62:2, pages 105-118.
Crossref
Crossref
Jelena M. Kao & Peter L. Greenberg. (2007) Myelodysplastic Syndromes: Impact of Recently Analyzed Variables for Modifying Current Classification Methods. Clinical Leukemia 1:3, pages 172-182.
Crossref
Crossref
Lars Matuszewski, Thorsten Persigehl, Alexander Wall, Norbert Meier, Ralf Bieker, Hendrik Kooijman, Bernd Tombach, Rolf Mesters, Wolfgang E. Berdel, Walter Heindel & Christoph Bremer. (2007) Assessment of Bone Marrow Angiogenesis in Patients with Acute Myeloid Leukemia by Using Contrast-enhanced MR Imaging with Clinically Approved Iron Oxides: Initial Experience. Radiology 242:1, pages 217-224.
Crossref
Crossref
Karen W.L. Yee, Anne Hagey, Srdan Verstovsek, Jorge Cortes, Guillermo Garcia-Manero, Susan M. O'Brien, Stefan Faderl, Deborah Thomas, William Wierda, Steven Kornblau, Alessandra Ferrajoli, Maher Albitar, Evelyn McKeegan, David R. Grimm, Toby Mueller, Rhonda R. Holley-Shanks, Leonardo Sahelijo, Gary B. Gordon, Hagop M. Kantarjian & Francis J. Giles. (2005) Phase 1 Study of ABT-751, a Novel Microtubule Inhibitor, in Patients with Refractory Hematologic Malignancies. Clinical Cancer Research 11:18, pages 6615-6624.
Crossref
Crossref
G Schuch, L Oliveira-Ferrer, S Loges, E Laack, C Bokemeyer, D K Hossfeld, W Fiedler & S Ergun. (2005) Antiangiogenic treatment with endostatin inhibits progression of AML in vivo. Leukemia 19:8, pages 1312-1317.
Crossref
Crossref